Floatz logo

Human Normal Immunoglobulin (Ivig)

Acquired Immunodeficiency

Takedaother_biologicalPhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Acquired Immunodeficiency cohort.

Same molecule, other indications

Human Normal Immunoglobulin (Ivig) is also rated in:

plasma cell myelomaActive
CCC
Indicative · Phase 3
54 / 100
View asset →
plasma cell neoplasmDormant
CCC
Indicative · Phase 1/2
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →